176 related articles for article (PubMed ID: 25551808)
41. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
Winding B; NicAmhlaoibh R; Misander H; Høegh-Andersen P; Andersen TL; Holst-Hansen C; Heegaard AM; Foged NT; Brünner N; Delaissé JM
Clin Cancer Res; 2002 Jun; 8(6):1932-9. PubMed ID: 12060638
[TBL] [Abstract][Full Text] [Related]
42. S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes.
Aggarwal A; Khera A; Singh I; Sandhir R
J Neurochem; 2015 Mar; 132(5):595-608. PubMed ID: 25187090
[TBL] [Abstract][Full Text] [Related]
43. The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis.
Too LK; Ball HJ; McGregor IS; Hunt NH
Brain Behav Immun; 2014 Aug; 40():252-68. PubMed ID: 24607660
[TBL] [Abstract][Full Text] [Related]
44. Recombinant ADAMTS 13 Attenuates Brain Injury After Intracerebral Hemorrhage.
Cai P; Luo H; Xu H; Zhu X; Xu W; Dai Y; Xiao J; Cao Y; Zhao Y; Zhao BQ; Fan W
Stroke; 2015 Sep; 46(9):2647-53. PubMed ID: 26251246
[TBL] [Abstract][Full Text] [Related]
45. [Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass].
Ge SL; Gong WH; Zhang CX; Zhang L; Han PH; Zhang SQ; Feng JB; Zhou DC
Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(1):57-61. PubMed ID: 20302758
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
47. Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats.
Lee JK; Kwak HJ; Piao MS; Jang JW; Kim SH; Kim HS
Acta Neurochir (Wien); 2011 Jun; 153(6):1321-9; discussion 1329. PubMed ID: 21120545
[TBL] [Abstract][Full Text] [Related]
48. Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
Tang J; Liu J; Zhou C; Alexander JS; Nanda A; Granger DN; Zhang JH
J Cereb Blood Flow Metab; 2004 Oct; 24(10):1133-45. PubMed ID: 15529013
[TBL] [Abstract][Full Text] [Related]
49. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
50. Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemia.
Lee K; Lee JS; Jang HJ; Kim SM; Chang MS; Park SH; Kim KS; Bae J; Park JW; Lee B; Choi HY; Jeong CH; Bu Y
Eur J Pharmacol; 2012 Aug; 689(1-3):89-95. PubMed ID: 22659584
[TBL] [Abstract][Full Text] [Related]
51. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9.
Sporer B; Koedel U; Paul R; Kohleisen B; Erfle V; Fontana A; Pfister HW
J Neuroimmunol; 2000 Jan; 102(2):125-30. PubMed ID: 10636480
[TBL] [Abstract][Full Text] [Related]
52. A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice.
Lee J; Weber M; Mejia S; Bone E; Watson P; Orr W
Eur J Cancer; 2001 Jan; 37(1):106-13. PubMed ID: 11165137
[TBL] [Abstract][Full Text] [Related]
53. Batimastat. BB 94, collagenase inhibitors-1.
Drugs R D; 1999 Feb; 1(2):139-41. PubMed ID: 10566008
[No Abstract] [Full Text] [Related]
54. [Effect of batimastat on the dynamic changes of matrix metalloproteinases in liver tissue during the development of hepatocellular carcinoma in rats].
Gao Y; Zhang Z; Jiang ZS; Fang SG; Sun EW; Liu J; Chen BH
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):570-1. PubMed ID: 14552732
[No Abstract] [Full Text] [Related]
55. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
56. Virulence Traits of a Serogroup C Meningococcus and Isogenic
Colicchio R; Pagliuca C; Ricci S; Scaglione E; Grandgirard D; Masouris I; Farina F; Pagliarulo C; Mantova G; Paragliola L; Leib SL; Koedel U; Pozzi G; Alifano P; Salvatore P
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718288
[TBL] [Abstract][Full Text] [Related]
57. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591
[TBL] [Abstract][Full Text] [Related]
58. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain.
Sood RR; Taheri S; Candelario-Jalil E; Estrada EY; Rosenberg GA
J Cereb Blood Flow Metab; 2008 Feb; 28(2):431-8. PubMed ID: 17700631
[TBL] [Abstract][Full Text] [Related]
59. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
Low JA; Johnson MD; Bone EA; Dickson RB
Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
[TBL] [Abstract][Full Text] [Related]
60. Melatonin reduced the elevated matrix metalloproteinase-9 level in a rat photothrombotic stroke model.
Jang JW; Lee JK; Lee MC; Piao MS; Kim SH; Kim HS
J Neurol Sci; 2012 Dec; 323(1-2):221-7. PubMed ID: 23046750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
